A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits

Drug Safety

Volumn 16, Issue 5, 1997, Pages 330-341

  Tonstad, Serena ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PHYTOSTEROL; VITAMIN;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; DIET SUPPLEMENTATION; DIETARY FIBER; GROWTH INHIBITION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LOW FAT DIET; NUTRITION; NUTRITIONAL DEFICIENCY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0031006799     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199716050-00004     Document Type: Article

References (120)

1. Holman RL. Atherosclerosis: a paediatric nutrition problem. Am J Clin Nutr 1961; 9: 565-9
2. Kwiterovich Jr PO. Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics 1986; 78: 349-62
3. Williams CL, Wynder EL, editors. Hyperlipidemia in childhood and the development of atherosclerosis. Ann N Y Acad Sci 1991; 623: 1-480
4. Strong JP, Malcom GT, Oalmann MC and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathol Int 1995; 45: 403-8
5. National Cholesterol Education Program. Report of the Expert Panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89: 525-84
6. European Atherosclerosis Society International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992; 2: 113-56
7. Akerblom HK, Chandra RK, Franklin FA, et al. Conclusions, guidelines and recommendations from the IUNS/WHO workshop: nutrition in the pediatric age group and later cardiovascular disease. J Am Coll Nutr 1992; 11 Suppl. S: 1S-2S
8. American Academy of Pediatrics. Committee on Nutrition: statement on cholesterol. Pediatrics 1992; 90: 469-73
9. ESPGAN Committee on Nutrition. Commitee report: childhood diet and prevention of coronary heart disease. J Pediatr Gastroenterol Nutr 1994; 19: 261-9
10. Zlotkin SH. A review of the Canadian 'Nutrition recommendations update: dietary fat and children'. J Nutr 1996; 126: 1022S-7S
11. Wray R, Neil HAW, Rees JAE. Screening for hyperlipidaemia in childhood: recommendations of the British Hyperlipidaemia Association. J R Coll Physicians London 1996; 30: 115-8
12. Ose L, Tonstad S. The detection and management of dyslipidaemia in children and adolescents. Acta Paediatr 1995; 84: 1213-5
13. Skovby F, Dyerberg J, Færgeman O, et al. Hyperlipidaemi hosbørn. Ugeskrift for Laeger 1993; 155: 810-4
14. Newman TB, Browner WS, Hulley SB. The case against childhood cholesterol screening. JAMA 1990: 264: 3039-43
15. Olson RE. The dietary recommendations of the American Academy of Pediatrics. Am J Clin Nutr 1995; 61: 271-3
16. Gillman MW, Lannon CM. Screening for hypercholesterolemia in children: the missing links. Ann Epidemiol 1991; 1: 559-65
17. Zlotkin SH. Reducing dietary intake of fat and cholesterol in children [letter]. JAMA 1995; 274; 1423-4
18. Newman TB, Garber AM, Holtzman NA, et al. Problems with the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Arch Pediatr Adolesc Med 1995; 149: 241-7
19. Weidman WH. Position statement: the 'cons' of cholesterol screening in children. J Am Coll Nutr 1992; 11 Suppl. S: 18S-9S
20. Holtzman NA. The great god cholesterol. Pediatrics 1991; 87: 943-5
21. Lauer RM, Clarke WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine Study. JAMA 1990; 264: 3034-8
22. Griffin TC, Christoffel KK, Binns HJ, et al. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatrics 1989; 84: 365-73
23. Dennison BA, Kikuchi DA, Srinivasan SR, et al. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr 1989; 115: 186-94
24. Shea S, Basch CE, Irigoyen M, et al. Failure of family history to predict high blood cholesterol among Hispanic preschool children. Prev Med 1990; 19: 443-55
25. Steiner NJ, Neinstein LS, Pennbridge J. Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors. Pediatrics 1991; 88: 269-75
26. Dennison BA, Jenkins PL, Pearson TA. Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics 1994; 94: 296-302
27. Primrose ED, Savage JM, Boreham CA, et al. Cholesterol screening and family history of vascular disease. Arch Dis Child 1994; 71: 239-42
28. Rona RJ, Qureshi S, Chinn S. Factors related to total cholesterol and blood pressure in British 9-year-olds. J Epidemiol Community Health 1996; 50: 512-8
29. Resnicow K, Cross D. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics 1993; 92: 347-54
30. Stein EA. Guidelines and methods for assessing pediatric hyperlipidemia. Curr Opin Lipidol 1992; 3: 395-8
31. Shepherd J, Cobbe SM, Ford I, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7
32. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9
33. Levine GN, Keaney Jr JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-21
34. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341: 1496-500
35. Porkka KVK, Viikari JSA, Taimela S, et al. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12 year follow-up. Am J Epidemiol 1994; 140: 1096-109
36. Labarthe DR. Coronary risk factors in childhood. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: from aetiology to public health. Oxford: Oxford University Press, 1992: 92-102
37. Rifai N, Neufeld E, Ahlstrom P, et al. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996; 98: 383-8
38. Neil HAW, Mant D. Cholesterol screening and life assurance. BMJ 1991; 302: 891-3
39. Rosenthal SL, Knauer-Black S, Stahl MP, et al. The psychological functioning of children with hypercholesterolemia and their families. Clin Pediatrics (Phila) 1993; 32: 135-41
40. Tonstad S. Familial hypercholesterolaemia: a pilot study of parents' and children's concerns. Acta Paediatr 1996; 85: 1307-13
41. Tonstad S, Nøvik TS, Vandvik IH. Psychosocial function during treatment for familial hypercholesterolemia. Pediatrics 1996; 98: 249-55
42. Tonstad S, Sivertsen S. Food dislikes and dietary intake in children with familial hypercholesterolemia and controls. Scand J Nutr 1996; 40: 146-50
43. Kennedy E, Goldberg J. What are American children eating? Implications for public policy. Nutr Rev 1995; 53: 111-26
44. Samuelson G, Bratteby L-E, Enghardt H, et al. Food habits and energy and nutrient intake in Swedish adolescents approaching the year 2000. Acta Paediatr Scand 1996; 415 Suppl.: 1-20
45. Frost Andersen L, Nes M, Sandstad B, et al. Dietary intake among Norwegian adolescents. Eur J Clin Nutr 1995; 49: 555-64
46. Michaelsen KF, Jorgensen MH. Dieiary fat content and energy density during infancy and childhood: the effect on energy intake and growth. Eur J Clin Nutr 1995; 49: 467-83
47. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). JAMA 1995; 273: 1429-35
48. Lifshitz F, Moses N. Growth failure: a complication of dietary treatment of hypercholesterolemia. Am J Dis Child 1989; 143: 537-42
49. Kleinman RE, Finberg LF, Klish WJ, et al. Dietary guidelines for children: US recommendations. J Nutr 1996; 126: 1028S-30S
50. Kaplan RM, Toshima MT. Does a reduced fat diet cause retardation in child growth? Prev Med 1992; 21: 33-52
51. Lifshitz F, Tarim O. Consideration about dietary fat restrictions for children. J Nutr 1996; 126: 1031S-41S
52. Harper AE. Dietary guidelines in perspective. J Nutr 1996; 126: 1042S-8S
53. Lapinleimu H, Viikari J, Jokinen E, et al. Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet 1995; 345: 471-6
54. Mertz, W, Tsui JC, Judd JT, et al. What are people really eating? The relation between energy intake derived from estimated diet records and intake determined to maintain body weight. Am J Clin Nutr 1991; 54: 291-5
55. Hegsted DM. What are American children eating? Implications for public policy [letter]. Nutr Rev 1996; 54: 67
56. Friedman G, Goldberg SJ. An evaluation of the safety of a low-saturated-fat, low-cholesterol diet beginning in infancy. Pediatrics 1976; 58: 655-7
57. Nicklas TA, Webber LS, Koschak ML, et al. Nutrient adequacy of low fat intakes for children: the Bogalusa Heart Study Pediatrics 1992; 89: 221-8
58. Vobecky JS, Vobecky J, Normand L. Risk and benefit of low fat intake in childhood. Ann Nutr Metab 1995; 39: 124-33
59. Nicklas TA, Myers L, Farris RP, et al. Nutritional quality of a high carbohydrate diet as consumed by children: the Bogalusa Heart Study. J Nutr 1996; 126: 1382-8
60. Tonstad S, Sivertsen M. Dietary adherence in familial hypercholesterolemia. Am J Clin Nutr. 1997; 65: 1018-26
61. Tonstad S, Sivertsen M. Relationship between dietary fat and energy and micronutrient intake. Arch Dis Child. In press
62. McPherson RS, Nichaman MZ, Kohl HW, et al. Intake and food sources of dietary fat among schoolchildren in The Woodlands. Texas. Pediatrics 1990; 86: 520-6
63. Ursin G, Ziegler RG, Subar AF, et al. Dietary patterns associated with a low-fat diet in the National Health Examination Follow-up Study: identification of potential confounders for epidemiologic analyses. Am J Epidemiol 1993; 137: 916-27
64. Assouline L, Levy E, Feoli-Fonseca JC, et al. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Pediatrics 1995; 96: 239-46
65. Niinikoski H, Viikari J, Rönnemaa T, et al. Prospective randomized trial of low-saturated-fat, low-cholesterol diet during the first 3 years of life. Circulation 1996; 94: 1386-93
66. Sanders T, Lynas J. Determinants of lipid and lipoprotein concentrations and the dietary management of hyperlipidaemia in childhood. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London, 1996: 41-9
67. Connor WE, Connor SL. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol 1993; 72: 42D-53D
68. Fernandes J, Dijkhuis-Stoffelsma R, Grooet PHE, et al. The effect of a virtually cholesterol-free, high-linoleic acid vegetarian diet on serum lipoproteins of children with familial hypercholesterolemia (type II-A). Acta Paediatr Scand 1981; 70: 677-82
69. Widhalm K, Brazda G, Schneider B, et al. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia. J Pediatr 1993; 123: 30-4
70. Gaddi A, Descovich GC, Noseda G, et al. Hypercholesterolaemia treated by soybean protein diet. Arch Dis Child 1987; 62: 274-8
71. Wolf G. High-fat, high-cholesterol diet raises plasma HDL cholesterol: studies on the mechanism of this effect. Nutr Rev 1996; 54: 34-5
72. Porkka KVK, Raitakari OT. Serum lipoproteins in children and young adults: determinants and treatment strategies. Curr Opin Lipidol 1996; 7: 183-7
73. Mietus-Snyder M, Baker AL, Neufeld EJ, et al. Effects of nutritional counselling on lipoprotein levels in a pediatric lipid clinic. Am J Dis Child 1993; 147: 378-81
74. Mann J. Position statement: nutrition options when reducing saturated fat intake. J Am Coll Nutr 1992; 11 Suppl. S: 82S-3S
75. Zavoral JH, Hannan P, Fields DJ, et al. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children. Am J Clin Nutr 1983; 38: 285-94
76. Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile effects of an oat-bran-supplemented, low fat diet in children with elevated serum cholesterol. Ann N Y Acad Sci 1991; 623: 429-31
77. Dennison HA, Levine DM. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia. J Pediatr 1993; 123: 24-9
78. Davidson MH, Dugan LD, Burns JH, et al. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr 1996; 63: 96-102
79. Becker M, Staab D, Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitosterol. J Pediatr 1993; 122: 296-6
80. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietart treatment of children with familial hypercholesterolemia. J Lipid Res 1995; 36: 1807-12
81. Goran A, Stankiewica H, Goldstein R, et al. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy. Pediatrics 1991; 88: 265-8
82. Glueck CJ, Fallat RW, Tsang RC. Pediatric familial type II hyperlipoproteinemia therapy with diet and cholestyramine resin. Pediatrics 1973; 52: 669-79
83. West RJ, Lloyd JK. Use of cholestyramine in treatment of children with familial hypercholesterolaemia. Arch Dis Child 1973; 48: 370-4
84. Wheeler KAH, West RJ, Lloyd JK, et al. Double-blind trial of bezafibrate in familial hypercholesteroalaemia. Arch Dis Child 1985; 60: 34-7
85. Reihnér E, Angelin B, Rudling M, et al. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 1990; 31: 2219-26
86. Angelin B, Leijd B, Hultcrantz R, et al. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 1990; 227: 201-6
87. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-64
88. Cashin-Hemphill L, Mack WJ, Pogoda JM, et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. JAMA 1990; 264: 3013-7
89. Dorr AE, Gundersen K, Schneider JC, et al. Colestipol hydrochloride in hypercholesterolemic patients: effect on serum cholesterol and mortality. J Chron Dis 1978; 31: 5-14
90. Farah JR, Kwiterovich PO, Neill CA. Dose-effect relation of cholestyramine in children and young adults with familial hypercholesterolaemia. Lancet 1977; 1: 59-63
91. West RJ, Lloyd JK. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet 1980; 2: 873-5
92. Groot PHE, Dijkhuis-Stoffelsma R, Grose WFA, et al. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Acta Paediatr Scand 1983; 72: 81-5
93. Superko HR, Greenland P, Manchester RA, et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Am J Cardiol 1992; 70: 135-40
94. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996; 129; 42-9
95. Tonstad S, Sivertsen M, Aksnes L, et al. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996; 74: 157-60
96. Liacouras CA, Coates PM, Gallagher PR, et al. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr 1993; 122: 477-82
97. Hansen D, Michaelsen KE, Skovby F. Growth during treatment of familial hypercholesterolemia. Acta Paediatr 1992; 81: 1023-5
98. Koletzko B, Kupke I, Wendel U. Treatment of hypercholesterolemia in children and adolescents. Acta Paediatr 1992; 81: 682-5
99. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut 1975; 16: 93-8
100. Tonstad S, Aksnes L. Fat soluble vitamin levels in familial hypercholesterolemia. J Pediatr 1997; 130: 274-80
101. Tonstad S, Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr 1996; 85: 1080-2
102. Tonstad S, Bing RF, Frohlich J, et al. Effectiveness of colestipol tablets vs granules in patients with moderate to severe hypercholesterolaemia. Clin Drug Invest 1995; 10: 257-63
103. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children [letter]. Lancet 1992; 339: 1488
104. Sinzinger H, Schmidt P, Pirich CH, et al. Treatment of hypercholesterolaemia in children. Lancet 1992; 340: 548-9
105. Sinzinger H, Mayr F, Schmid P, et al. Sleep disturbance and appetite loss after lovastatin. Lancet 1994, 343: 973
106. Knipscheer HC, Boelen CCA, Kastelein JJP, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996, 39: 867-71
107. Lambert M, Lupien P-J, Gagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 1996; 97: 619-28
108. Illingworth DR. Drug therapy for hyperlipidaemia in childhood. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London, 1996; 51-65
109. Steinmetz J, Morin C, Panek E, et al. Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clin Chim Acta 1981; 112; 43-53
110. Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993; 92: 78-82
111. Kelder SH, Perry CL, Klepp KI, et al. Longitudinal tracking of adolescent smoking, physical activity and food choice behaviors. Am J Public Health 1994; 84: 1121-6
112. Diller PM, Huster GA, Leach AD, et al. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for children and adolescents. J Pediatr 1995; 126: 345-52
113. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: MeGraw-Hill Inc., 1995; 1981-2030
114. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and controls. Arterioscler Thromb Vasc Biol 1996; 16: 984-91
115. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50-5
116. Hegele RA, Connelly PW, Cullen-Dean G. Elevated plasma lipoprotein(a) associated with abnormal stress thallium scans in children with familial hypercholesterolemia. Am J Cardiol 1993; 72: 402-6
117. Lloyd JK. Cholesterol: should we screen all children or change the diet of all children. Acta Paediatr Scand 1991; 373 Suppl.: 66-72
118. Gillman MW. Screening for familial hypercholesterolemia in childhood. Am J Dis Child 1993; 147: 393-6
119. Wray R, Neil A, Rees A. Hyperlipidaemia in childhood: a screening strategy. UK recommendations. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London. 1996; 99-105
120. Fraser GE. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994; 59 Suppl.: 1117-23